Featured Research

from universities, journals, and other organizations

Attitudes toward end-of-life care: A survey of cancer patients and others in Korea

Date:
May 30, 2011
Source:
Canadian Medical Association Journal
Summary:
Attitudes toward end-of-life care for cancer patients vary, but most patients, family members, oncologists and members of the public are receptive to withdrawing futile life-sustaining treatments in people who are dying, found a Korean study.

Attitudes toward end-of-life care for cancer patients vary, but most patients, family members, oncologists and members of the public are receptive to withdrawing futile life-sustaining treatments in people who are dying, found a Korean study in CMAJ (Canadian Medical Association Journal).

The study, by researchers in Korea, aimed to determine attitudes towards end-of-life care, as most previous studies looked only at euthanasia and physician-assisted suicide. The researchers surveyed 3840 people, including 1242 cancer patients, 1289 family caregivers, 303 oncologists from 17 hospitals from across the country and 1006 members of the general Korean population.

"In this survey of attitudes toward critical interventions at the end of life of terminally ill patients, the most interesting finding was that most of the participants in each of the four study groups -- patients, family caregivers, oncologists and members of the general public -- showed a positive attitude toward the withdrawal of futile life-sustaining treatment and active pain control," writes Dr. Young Ho Yun, National Cancer Center, Goyang, Korea, with coauthors.

Palliative care in Korea is still fairly rare, and oncologists and family physicians in institutions provide medical care.

"In the absence of effective palliation, it is no surprise that patients and others would choose a route that avoids the prolongation of suffering," write the authors.

Patients and the general public generally favoured patient autonomy and hastening the dying process but oncologists and family caregivers were more opposed to this option. Age, sex and religious beliefs were associated with acceptance of euthanasia and physician-assisted suicide.


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Cite This Page:

Canadian Medical Association Journal. "Attitudes toward end-of-life care: A survey of cancer patients and others in Korea." ScienceDaily. ScienceDaily, 30 May 2011. <www.sciencedaily.com/releases/2011/05/110530152340.htm>.
Canadian Medical Association Journal. (2011, May 30). Attitudes toward end-of-life care: A survey of cancer patients and others in Korea. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2011/05/110530152340.htm
Canadian Medical Association Journal. "Attitudes toward end-of-life care: A survey of cancer patients and others in Korea." ScienceDaily. www.sciencedaily.com/releases/2011/05/110530152340.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins